Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 13-03-2014 | Practice Area: | Corporate and M&A |
| Deal Title: | Bpifrance Innovative Biotherapies Investment in GenSight Biologics | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
King and Wood Mallesons SJ Berwin advised Bpifrance, through its Innovative Biotherapies and Rare Diseases fund, on the acquisition of a EUR3 million stake in GenSight Biologics.
This stake is in addition to the April 2013 series A financing, in which Index Ventures, Abingworth Management, Novartis Venture Fund and Versant Ventures invested EUR32 million in in the biopharmaceutical company.
On the very first investment of its Innovative Biotherapies and Rare Diseases fund, Bpifrance was advised by King and Wood Mallesons SJ Berwin Corporate partner, Pierre-Louis Perin.
|
||
| Financial Center: | Paris | Value: | 0.00-100.00 |
| Advised Party: | Private Equity Investor | Law Firm | King & Wood Mallesons SJ Berwin |
| Target Company Jurisdiction | France | Acquiror Jurisdiction | France |
| Classification: |
Financial Buyer Acquisitions Minority Investment |
Lawyer | Pierre-Louis Perin |
